Skip to main content

Bloodstream Infection

1
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
1
colistin/polymyxin B + sulbactamPhase 41 trial
Active Trials
NCT07004049Recruiting600Est. Dec 2028
ExThera Medical
ExThera MedicalCA - Martinez
1 program
Seraph 100,The Microbind Affinity Blood FilterN/A1 trial
Active Trials
NCT04260789Unknown232Est. Aug 2022
Roche
RocheSTAVANGER NORWAY, Norway
1 program
cobas eplex multiplex PCRN/A1 trial
Active Trials
NCT06576258Recruiting200Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Alliance Pharmaceuticalscolistin/polymyxin B + sulbactam
Rochecobas eplex multiplex PCR
ExThera MedicalSeraph 100,The Microbind Affinity Blood Filter

Clinical Trials (3)

Total enrollment: 1,032 patients across 3 trials

NCT07004049Alliance Pharmaceuticalscolistin/polymyxin B + sulbactam

Optimising TREATment for Severe Gram-Negative Bacterial Infections

Start: Apr 2025Est. completion: Dec 2028600 patients
Phase 4Recruiting
NCT06576258Rochecobas eplex multiplex PCR

The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia

Start: Nov 2024Est. completion: Dec 2025200 patients
N/ARecruiting
NCT04260789ExThera MedicalSeraph 100,The Microbind Affinity Blood Filter

Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection

Start: Aug 2020Est. completion: Aug 2022232 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 1,032 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.